Nerea Vega García
After obtaining her Degree in Human Biology (Pompeu Fabra University) in 2012, Nerea Vega improve her skills in clinical laboratory techniques at the Master Laboratory of Clinical Analysis (Pompeu Fabra University) in 2013.
After starting her doctoral research at the Laboratory of Hematology of the SJD Barcelona Children’s Hospital, included in the Group of Tumors of the Development of the Institut de Recerca Sant Joan de Déu. In 2018 s he obtained her PhD in Medicine and Translational Research (Universitat of Barcelona).
Her research, entitled "Study of the histone deacetylase (HDAC) expression profile in paediatric patients with acute leukaemia" focused on the study of the expression profile of HDAC and other corregulators in order to improve our knowledge on their role in paediatric leukaemia and identify possible biomarkers and/or therapeutic targets, especially in high-risk leukemias such as infants and MLL-rearranged.
Currently, and thanks to the experience obtained during these 7 years in the Hematology Laboratory in molecular techniques, and after attending several formations (national and international) She has participated in the implementation of NGS techniques for the molecular diagnosis of patients with paediatric acute leukaemia. Moreover, she participates in national and international scientific congresses and associations, including the European Hematology Association (EHA).
Professional network profiles
- Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, José Luis Dapena Díaz, Rives-Sola S, Ramirez M and Camós-Guijosa M Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. Frontiers in pediatrics . 8: 614521-614521.
- Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garcés C, Alonso J, Barragán E, Fernández G, Hernández-Sánchez JM, Martín-Izquierdo M, Joan Maynou Fernández, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Sola S, Dapena JL, Ramírez M and Camós-Guijosa M Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia. Journal of Personalized Medicine . 10(4): 244.
- Montano, A, Matorra-Miguel, M, Forero-Castro, M, Lumbreras, E, Santos, S, Miguel, C, Fuster, JL, De las Heras, N, Garcia-de Coca, A, Sierra, M, Davila, J, De la Fuente, I, Olivier, C, Olazabal, J, Martinez, J, Vega-García N, Camós-Guijosa M, Gonzalez, T, Hernandez-Rivas, JM and Benito, R APPLICATION OF A NGS DIAGNOSTIC PANEL TO IMPROVE AND REFINE THE STRATIFICATION OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA B HAEMATOLOGICA . 105: 26-26.
Drs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a previously noticed population of pre-leukemic cells might be responsible for some relapses in B-cell acute lymphoblastic leukemia (B-ALL).